PDB Short entry for 1WCO HEADER PEPTIDE/ANTIBIOTIC 19-NOV-04 1WCO TITLE THE SOLUTION STRUCTURE OF THE NISIN-LIPID II COMPLEX CAVEAT 1WCO MUB A 1 HAS WRONG CHIRALITY AT ATOM C9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALA-FGA-LYS-DAL-DAL PEPTIDE; COMPND 3 CHAIN: L; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: LANTIBIOTIC; COMPND 6 CHAIN: N SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MONARTHROPALPUS FLAVUS; SOURCE 3 ORGANISM_TAXID: 71816; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: LACTOCOCCUS LACTIS; SOURCE 6 ORGANISM_TAXID: 1358 KEYWDS PEPTIDE-ANTIBIOTIC COMPLEX, LANTIBIOTIC, ANTIMICROBIAL, BACTERIOCIN, KEYWDS 2 THIOESTER, PORE FORMATION, PYROPHOSPHATE CAGE, FOOD PRESERVATIVE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.-T.D.HSU,E.BREUKINK,E.TISCHENKO,M.A.G.LUTTERS,B.DE KRUIJFF, AUTHOR 2 R.KAPTEIN,A.M.J.J.BONVIN,N.A.J.VAN NULAND REVDAT 9 29-JUL-20 1WCO 1 CAVEAT COMPND REMARK HETNAM REVDAT 9 2 1 LINK SITE ATOM REVDAT 8 08-JUL-20 1WCO 1 CAVEAT COMPND SOURCE REMARK REVDAT 8 2 1 DBREF SEQADV SEQRES HET REVDAT 8 3 1 HETNAM HETSYN FORMUL LINK REVDAT 8 4 1 SITE ATOM REVDAT 7 17-JAN-18 1WCO 1 CAVEAT JRNL REMARK ATOM REVDAT 6 13-JUL-11 1WCO 1 VERSN REVDAT 5 24-FEB-09 1WCO 1 VERSN REVDAT 4 15-MAY-07 1WCO 1 REMARK SEQRES MODRES HET REVDAT 4 2 1 HETNAM HETSYN FORMUL LINK REVDAT 4 3 1 HETATM TER ENDMDL MODEL REVDAT 4 4 1 CONECT REVDAT 3 01-MAR-06 1WCO 1 HETATM REVDAT 2 14-MAR-05 1WCO 1 SPRSDE REVDAT 1 07-MAR-05 1WCO 0 SPRSDE 07-MAR-05 1WCO 1UZT JRNL AUTH S.T.HSU,E.BREUKINK,E.TISCHENKO,M.A.LUTTERS,B.DE KRUIJFF, JRNL AUTH 2 R.KAPTEIN,A.M.BONVIN,N.A.VAN NULAND JRNL TITL THE NISIN-LIPID II COMPLEX REVEALS A PYROPHOSPHATE CAGE THAT JRNL TITL 2 PROVIDES A BLUEPRINT FOR NOVEL ANTIBIOTICS. JRNL REF NAT. STRUCT. MOL. BIOL. V. 11 963 2004 JRNL REFN ISSN 1545-9993 JRNL PMID 15361862 JRNL DOI 10.1038/NSMB830 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.-T.D.HSU,E.BREUKINK,B.DE KRUIJFF,R.KAPTEIN,A.M.J.J.BONVIN, REMARK 1 AUTH 2 N.A.J.VAN NULAND REMARK 1 TITL MAPPING THE TARGETED MEMBRANE PORE FORMATION MECHANISM BY REMARK 1 TITL 2 SOLUTION NMR: THE NISIN Z AND LIPID II INTERACTION IN SDS REMARK 1 TITL 3 MICELLES REMARK 1 REF BIOCHEMISTRY V. 41 7670 2002 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12056898 REMARK 1 DOI 10.1021/BI025679T REMARK 1 REFERENCE 2 REMARK 1 AUTH E.BREUKINK,I.WIEDEMANN,C.VAN KRAAIJ,O.P.KUIPERS,H.G.SAHL, REMARK 1 AUTH 2 B.DE KRUIJFF REMARK 1 TITL USE OF THE CELL WALL PRECURSOR LIPID II BY A PORE- FORMING REMARK 1 TITL 2 PEPTIDE ANTIBIOTIC REMARK 1 REF SCIENCE V. 286 2361 1999 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 10600751 REMARK 1 DOI 10.1126/SCIENCE.286.5448.2361 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.LINGE,M.A.WILLIAMS,C.A.E.M.SPRONK,A.M.J.J.BONVIN,M.NILGES REMARK 1 TITL REFINEMENT OF PROTEIN STRUCTURES IN EXPLICIT SOLVENT REMARK 1 REF PROTEINS: STRUCT.,FUNCT., V. 50 496 2003 REMARK 1 REF 2 GENET. REMARK 1 REFN ISSN 0887-3585 REMARK 1 PMID 12557191 REMARK 1 DOI 10.1002/PROT.10299 REMARK 1 REFERENCE 4 REMARK 1 AUTH C.DOMINGUEZ,R.BOELENS,A.M.J.J.BONVIN REMARK 1 TITL HADDOCK: A PROTEIN-PROTEIN DOCKING APPROACH BASED ON REMARK 1 TITL 2 BIOCHEMICAL OR BIOPHYSICAL INFORMATION REMARK 1 REF J.AM.CHEM.SOC. V. 125 1731 2003 REMARK 1 REFN ISSN 0002-7863 REMARK 1 PMID 12580598 REMARK 1 DOI 10.1021/JA026939X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE. THE ENSEMBLE OF STRUCTURES IS SUPERIMPOSED REMARK 3 ON THE CA OF NISIN RESIDUES 1-12 (CHAIN N), THE HEAVY ATOMS OF REMARK 3 MURNAC, PYROPHOSPHATE AND THE FIRST ISOPRENE OF 3-LIPID II REMARK 3 (CHAIN L) AS THESE ARE THE ONLY SEGMENTS THAT HAVE SUFFICIENT REMARK 3 DISTANCE RESTRAINTS TO DEFINE THE COMPLEX STRUCTURE. OTHER REMARK 3 RESIDUES NAMELY RESIDUES 13-34 (ESPECIALLY RESIDUES 20-34) OF REMARK 3 NISIN, THE PENTAPEPTIDE AND TERMINAL ISOPRENE UNITS OF 3-LIPID REMARK 3 II ARE FLEXIBLE AS SUPPORTED BY DYNAMICS DATA. THE ATOM REMARK 3 OCCUPANCY OF THE C- TERMINAL TAIL OF NISIN (RESIDUES 20-34) HAS REMARK 3 BEEN MODIFIED TO BE 0.3 TO REFLECT THEIR DISORDER/FLEXIBILITY. REMARK 4 REMARK 4 1WCO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1290021726. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300.0 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 100% D6-DMSO REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1H-15N CT HSQC; 31P 1D; 1H-13C REMARK 210 HSQC; 1H-13C HMBC; 1H-15N-NOESY REMARK 210 HSQC; 1H-1H NOESY; 1H-15N TOCSY- REMARK 210 HSQC; 1H-1H TOCSY; 1H-1H COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ; 900 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW VIEW, CNS REMARK 210 METHOD USED : HADDOCK REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : RMSD CLUSTERING AND LOWEST TOTAL REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING MULTIDIMENSIONAL NMR REMARK 210 SPECTROSCOPY ON 15N-LABELLED NISIN IN COMPLEX WITH UNLABELLED 3- REMARK 210 LIPID II. INTERMOLECULAR HYDROGEN BONDS WERE IDENTIFIED AND USED REMARK 210 IN STRUCTURAL CALCULATION BY 31P- EDITED 1H-15N CT HSQC. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, N, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 NISIN Z IS A LANTIBIOTIC. THE LANTIBIOTICS REMARK 400 ARE CHARACTERIZED BY LANTHIONINE AND/OR METHYLLANTHIONINE REMARK 400 NONPROTEINOGENIC AMINO ACIDS. REMARK 400 HERE, NISIN Z IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: NISIN Z REMARK 400 CHAIN: N REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 34 REMARK 400 DESCRIPTION: NISIN Z IS A PENTACYCLIC PEPTIDE. THIOETHER BONDS REMARK 400 WITH CYSTEINE RESULT IN FIVE CYCLIC STRUCTURES ALONG REMARK 400 THE PEPTIDE CHAIN. REMARK 400 CROSSLINK 3-7 METHYLLANTHIONINE (DAL-CYS) REMARK 400 CROSSLINK 8-11 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 13-19 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 23-26 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 25-28 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 REMARK 400 THE NISIN A IS POLYPEPTIDE, A MEMBER OF LANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: NISIN A REMARK 400 CHAIN: N REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: Nisin Z is a heptacyclic peptide. Post Translational REMARK 400 maturation of lantibiotics involves the enzymic REMARK 400 conversion of Thr, and Ser into dehydrated AA and REMARK 400 the formation of thioether bonds with cysteine. REMARK 400 Thioether bonds with cysteine result in five cyclic REMARK 400 structures along the peptide chain. This is followed REMARK 400 by membrane translocation and cleavage of the REMARK 400 modified precursor. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ3 LYS L 5 O DAL L 7 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 DBB N 8 -58.97 147.76 REMARK 500 1 LYS N 12 1.93 -151.30 REMARK 500 1 MET N 17 -46.71 -154.38 REMARK 500 1 CYS N 19 82.90 63.18 REMARK 500 1 ASN N 20 -81.18 -57.88 REMARK 500 1 HIS N 31 -82.45 -126.21 REMARK 500 2 DAL L 6 -73.98 -71.81 REMARK 500 2 DBB N 13 46.61 -73.72 REMARK 500 2 MET N 17 -33.77 -160.00 REMARK 500 2 CYS N 19 91.33 65.39 REMARK 500 2 MET N 21 39.53 73.82 REMARK 500 3 DAL L 6 21.26 -74.60 REMARK 500 3 DBB N 8 -53.57 150.47 REMARK 500 3 DBB N 13 46.83 -73.72 REMARK 500 3 MET N 17 -30.53 -138.14 REMARK 500 3 CYS N 19 79.16 60.11 REMARK 500 3 ASN N 20 -80.10 -68.09 REMARK 500 3 MET N 21 -31.16 75.27 REMARK 500 3 DBB N 23 38.88 174.54 REMARK 500 3 ALA N 24 74.54 -117.37 REMARK 500 3 ILE N 30 55.63 -90.11 REMARK 500 4 DAL L 6 -82.63 -178.22 REMARK 500 4 LEU N 6 68.85 -101.79 REMARK 500 4 CYS N 7 99.10 -63.52 REMARK 500 4 DBB N 8 -57.27 150.92 REMARK 500 4 DBB N 13 44.97 -73.79 REMARK 500 4 MET N 17 -36.02 -150.61 REMARK 500 4 CYS N 19 87.97 70.22 REMARK 500 4 MET N 21 -49.92 74.53 REMARK 500 5 DAL L 6 40.04 145.50 REMARK 500 5 DBB N 8 -53.07 153.14 REMARK 500 5 DBB N 13 25.69 -81.60 REMARK 500 5 MET N 17 -57.69 -149.99 REMARK 500 5 CYS N 19 70.83 65.63 REMARK 500 5 ASN N 20 -81.51 70.51 REMARK 500 6 DAL L 6 46.55 -75.27 REMARK 500 6 CYS N 7 90.44 -59.40 REMARK 500 6 DBB N 8 -54.95 150.13 REMARK 500 6 DBB N 13 32.70 -73.93 REMARK 500 6 MET N 17 -42.41 -152.97 REMARK 500 6 ASN N 20 -23.20 174.42 REMARK 500 6 ILE N 30 32.34 -91.79 REMARK 500 7 DAL L 6 -37.64 170.25 REMARK 500 7 CYS N 7 99.45 -59.99 REMARK 500 7 DBB N 8 -53.50 146.75 REMARK 500 7 DBB N 13 52.35 -70.51 REMARK 500 7 MET N 17 -58.47 -136.07 REMARK 500 7 CYS N 19 177.59 64.80 REMARK 500 7 ASN N 20 -71.63 -119.19 REMARK 500 7 MET N 21 -47.13 73.57 REMARK 500 REMARK 500 THIS ENTRY HAS 129 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 1 FDF L 101 REMARK 610 2 FDF L 101 REMARK 610 3 FDF L 101 REMARK 610 4 FDF L 101 REMARK 610 5 FDF L 101 REMARK 610 6 FDF L 101 REMARK 610 7 FDF L 101 REMARK 610 8 FDF L 101 REMARK 610 9 FDF L 101 REMARK 610 10 FDF L 101 REMARK 610 11 FDF L 101 REMARK 610 12 FDF L 101 REMARK 610 13 FDF L 101 REMARK 610 14 FDF L 101 REMARK 610 15 FDF L 101 REMARK 610 16 FDF L 101 REMARK 610 17 FDF L 101 REMARK 610 18 FDF L 101 REMARK 610 19 FDF L 101 REMARK 610 20 FDF L 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ1 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE REMARK 900 RELATED ID: 1MQX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN MEOH/H2O REMARK 900 MIXTURE REMARK 900 RELATED ID: 1MQY RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC MICELLES REMARK 900 RELATED ID: 1MQZ RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN BOUND TO LIPID REMARK 900 II IN DPC MICELLES REMARK 900 RELATED ID: 1QOW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TUPE B LANTIBIOTIC MERSACIDIN REMARK 900 RELATED ID: 1W9N RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X REMARK 900 RELATED ID: 2DDE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED WITH REMARK 900 LYSOPHOSPHATIDYLETHANOLAMINE REMARK 900 RELATED ID: 2KTN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT REMARK 900 LANTIBIOTIC SYSTEM LICHENICIDIN VK21 A1 REMARK 900 RELATED ID: 2KTO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT REMARK 900 LANTIBIOTIC LICHENICIDIN VK21 A2 DBREF 1WCO L 3 7 PDB 1WCO 1WCO 3 7 DBREF 1WCO N 1 34 UNP Q7BB86 Q7BB86_9LACT 24 57 SEQADV 1WCO DAL N 3 UNP Q7BB86 SER 26 CONFLICT SEQADV 1WCO DBB N 8 UNP Q7BB86 THR 31 CONFLICT SEQADV 1WCO DBB N 13 UNP Q7BB86 THR 36 CONFLICT SEQADV 1WCO DBB N 23 UNP Q7BB86 THR 46 CONFLICT SEQADV 1WCO DBB N 25 UNP Q7BB86 THR 48 CONFLICT SEQRES 1 L 5 ALA FGA LYS DAL DAL SEQRES 1 N 34 ILE DBU DAL ILE DHA LEU CYS DBB PRO GLY CYS LYS DBB SEQRES 2 N 34 GLY ALA LEU MET GLY CYS ASN MET LYS DBB ALA DBB CYS SEQRES 3 N 34 ASN CYS SER ILE HIS VAL DHA LYS MODRES 1WCO DBU N 2 THR MODIFIED RESIDUE MODRES 1WCO DHA N 5 SER MODIFIED RESIDUE MODRES 1WCO DHA N 33 SER MODIFIED RESIDUE HET FGA L 4 15 HET DAL L 6 10 HET DAL L 7 11 HET DBU N 2 11 HET DAL N 3 9 HET DHA N 5 8 HET DBB N 8 12 HET DBB N 13 12 HET DBB N 23 12 HET DBB N 25 12 HET DHA N 33 8 HET MUB A 1 35 HET NAG A 2 28 HET FDF L 101 48 HETNAM FGA GAMMA-D-GLUTAMIC ACID HETNAM DAL D-ALANINE HETNAM DBU (2Z)-2-AMINOBUT-2-ENOIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM DBB D-ALPHA-AMINOBUTYRIC ACID HETNAM MUB N-ACETYL-ALPHA-MURAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FDF (2E,6E)-12-FLUORO-11-(FLUOROMETHYL)-3,7-DIMETHYLDODECA- HETNAM 2 FDF 2,6,10-TRIEN-1-YL TRIHYDROGEN DIPHOSPHATE HETSYN FGA D-GLUTAMIC ACID HETSYN DBU Z-DEHYDROBUTYRINE HETSYN DHA 2,3-DIDEHYDROALANINE FORMUL 1 FGA C5 H9 N O4 FORMUL 1 DAL 3(C3 H7 N O2) FORMUL 2 DBU C4 H7 N O2 FORMUL 2 DHA 2(C3 H5 N O2) FORMUL 2 DBB 4(C4 H9 N O2) FORMUL 3 MUB C11 H19 N O8 FORMUL 3 NAG C8 H15 N O6 FORMUL 4 FDF C15 H26 F2 O7 P2 HELIX 1 1 DBB N 8 DBB N 13 1 6 LINK C ALA L 3 N FGA L 4 1555 1555 1.32 LINK N ALA L 3 C10 MUB A 1 1555 1555 1.33 LINK CD FGA L 4 N LYS L 5 1555 1555 1.32 LINK C LYS L 5 N DAL L 6 1555 1555 1.33 LINK C DAL L 6 N DAL L 7 1555 1555 1.34 LINK PB FDF L 101 O1 MUB A 1 1555 1555 1.61 LINK C ILE N 1 N DBU N 2 1555 1555 1.34 LINK C DBU N 2 N DAL N 3 1555 1555 1.32 LINK C DAL N 3 N ILE N 4 1555 1555 1.32 LINK CB DAL N 3 SG CYS N 7 1555 1555 1.79 LINK C ILE N 4 N DHA N 5 1555 1555 1.34 LINK C DHA N 5 N LEU N 6 1555 1555 1.32 LINK C CYS N 7 N DBB N 8 1555 1555 1.32 LINK C DBB N 8 N PRO N 9 1555 1555 1.35 LINK CB DBB N 8 SG CYS N 11 1555 1555 1.82 LINK C LYS N 12 N DBB N 13 1555 1555 1.33 LINK C DBB N 13 N GLY N 14 1555 1555 1.33 LINK CB DBB N 13 SG CYS N 19 1555 1555 1.83 LINK C LYS N 22 N DBB N 23 1555 1555 1.32 LINK C DBB N 23 N ALA N 24 1555 1555 1.33 LINK CB DBB N 23 SG CYS N 26 1555 1555 1.82 LINK C ALA N 24 N DBB N 25 1555 1555 1.32 LINK C DBB N 25 N CYS N 26 1555 1555 1.32 LINK CB DBB N 25 SG CYS N 28 1555 1555 1.82 LINK C VAL N 32 N DHA N 33 1555 1555 1.33 LINK C DHA N 33 N LYS N 34 1555 1555 1.32 LINK O4 MUB A 1 C1 NAG A 2 1555 1555 1.42 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000